Case Studies
LeafLink Releases 2026 Wholesale Cannabis Pricing Guide
NEW YORK – LeafLink, a unified B2B marketplace and technology ...
Verano Reports Q4 and FY 2025 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for ...
Cannabinoids and Fatty Liver Disease: Emerging Research Highlights a Growing Health Challenge for Seniors
LOS ANGELES- A growing body of scientific research is examining how ...
Czech Republic Approves Psilocybin Therapy Guidelines for 2026
PRAGUE – The Czech Republic has taken a measured step toward integrating psychedelic-assisted therapy into its healthcare system, approving detailed rules that will permit the controlled use of psilocybin for select patients beginning in January ...
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
Organigram Reports Q4 2025 Financial and Full Fiscal Year Results
TORONTO – Organigram Global Inc. released its record Q4 and fiscal 2025 results, showing substantial gains in revenue and profitability metrics despite a quarterly net loss tied to one-time charges. For the fourth quarter, gross ...
Verano Pushes Digital Voting as Postal Strike Disrupts Shareholder Materials
CHICAGO – Verano Holdings Corp. is telling investors to submit votes electronically for its special meeting next month, citing delays from Canada's postal workers strike. The company released a statement warning that physical copies of ...
Psilocybin Review Points to Rapid Relief for Treatment-Resistant Depression
LOS ANGELES – A new systematic review of clinical studies underscores psilocybin's potential to deliver quick and lasting reductions in depressive symptoms, offering a targeted option for patients who see little benefit from standard medications. ...
Vireo Takes 86% Stake in Schwazze’s Convertible Notes in $62M Deal
DENVER – Vireo Growth Inc., a multistate Cannabis operator, has entered into definitive agreements to purchase about 86% of the senior secured convertible notes held by Medicine Man Technologies Inc., which operates as Schwazze, for ...
France Upholds Pesticide Ban, Guaranteeing Survival of the Bees
LOS ANGELES- Over the past decade, France has stood at the center of Europe’s fight to protect pollinators from the devastating effects of pesticides. In 2018, the nation became the first EU member to ban ...
Czech Republic Approves Psilocybin Therapy Guidelines for 2026
PRAGUE – The Czech Republic has taken a measured step toward integrating psychedelic-assisted therapy into its healthcare system, approving detailed rules that will permit the controlled use of psilocybin for select patients beginning in January ...
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
Organigram Reports Q4 2025 Financial and Full Fiscal Year Results
TORONTO – Organigram Global Inc. released its record Q4 and fiscal 2025 results, showing substantial gains in revenue and profitability metrics despite a quarterly net loss tied to one-time charges. For the fourth quarter, gross ...
